FDA approves new weight loss drug Zepbound
FDA approves new weight loss drug Zepbound - CBS News
Tag: loss
FDA approves a new weight loss drug, Zepbound from Eli Lilly
The Food and Drug Administration approved a request by Eli Lilly on Wednesday to begin marketing its tirzepatide medication, which ...
Warren Buffett’s Berkshire posts loss as stocks fall, operating profit rises
Warren Buffett's Berkshire Hathaway Inc on Saturday posted its first overall quarterly loss in a year as the prices of ...
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
Pfizer on Tuesday reported a narrower-than-expected adjusted loss for the third quarter as the drugmaker recorded charges largely related to ...
Paytm Q2 Results: Loss narrows to Rs 290 crore; revenue jumps 32% YoY
Fintech major Paytm has narrowed its losses for the quarter ended September 2023 to Rs 290 crore compared with Rs ...
Grayscale ETF Case’s Final Word Coming in Federal Court as SEC Loss Formalized
Grayscale Investments is waiting for a federal court tomorrow or soon after to formalize the defeat it handed the U.S. ...
Tata Steel arm TCIL Q2 net loss narrows to Rs 2.29 crore
The Tin Plate Company of India Ltd (TCIL) on Monday said its net loss had narrowed to Rs 2.29 crore ...
‘Miracle drug’ euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
Two experts see major challenges facing the adoption of new obesity drugs.Dr. Kavita Patel, a physician and NBC News medical ...
SEC Won’t Appeal Loss in Grayscale Case, Boosting the Odds GBTC Can Become a Bitcoin ETF
The Securities and Exchange Commission won’t appeal a court’s scathing reversal of its decision not to let Grayscale convert its ...
Weight loss drugs Ozempic, Wegovy linked to severe stomach problems, study finds
Weight loss drugs Ozempic, Wegovy linked to severe stomach problems, study finds - CBS News
